Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Xylans | 2 | 2016 | 22 | 0.580 |
Why?
|
| Stomach Neoplasms | 2 | 2016 | 192 | 0.570 |
Why?
|
| Protective Agents | 1 | 2015 | 22 | 0.520 |
Why?
|
| Carcinoma, Ehrlich Tumor | 2 | 2019 | 17 | 0.480 |
Why?
|
| Esophageal Neoplasms | 1 | 2015 | 124 | 0.470 |
Why?
|
| Hematopoietic System | 1 | 2013 | 3 | 0.460 |
Why?
|
| Whole-Body Irradiation | 1 | 2013 | 8 | 0.460 |
Why?
|
| Iron | 1 | 2015 | 204 | 0.460 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 14 | 0.450 |
Why?
|
| Radiation Injuries | 1 | 2013 | 23 | 0.450 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2019 | 193 | 0.440 |
Why?
|
| Embolism, Fat | 1 | 2004 | 1 | 0.260 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2004 | 2 | 0.260 |
Why?
|
| Phosphatidylglycerols | 1 | 2004 | 11 | 0.260 |
Why?
|
| Amphotericin B | 1 | 2004 | 24 | 0.260 |
Why?
|
| Phosphatidylcholines | 1 | 2004 | 45 | 0.260 |
Why?
|
| Adenoma, Islet Cell | 1 | 2004 | 1 | 0.250 |
Why?
|
| Duodenal Diseases | 1 | 2004 | 3 | 0.250 |
Why?
|
| Choristoma | 1 | 2004 | 4 | 0.250 |
Why?
|
| Duodenal Ulcer | 1 | 2004 | 5 | 0.250 |
Why?
|
| Pancreas | 1 | 2004 | 32 | 0.240 |
Why?
|
| Antifungal Agents | 1 | 2004 | 147 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 106 | 0.220 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 756 | 0.190 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 239 | 0.180 |
Why?
|
| Melanosis | 1 | 2019 | 3 | 0.180 |
Why?
|
| Colonic Diseases | 1 | 2019 | 11 | 0.180 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2019 | 30 | 0.170 |
Why?
|
| Methylnitronitrosoguanidine | 2 | 2016 | 6 | 0.170 |
Why?
|
| Rats, Wistar | 2 | 2016 | 202 | 0.160 |
Why?
|
| Apoptosis | 3 | 2019 | 1317 | 0.160 |
Why?
|
| Stomach | 1 | 2016 | 43 | 0.140 |
Why?
|
| Animals | 7 | 2019 | 14307 | 0.140 |
Why?
|
| Mice | 5 | 2019 | 5668 | 0.130 |
Why?
|
| Free Radicals | 1 | 2015 | 72 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2013 | 1349 | 0.130 |
Why?
|
| Organ Size | 1 | 2015 | 148 | 0.130 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2013 | 2 | 0.120 |
Why?
|
| Lip Neoplasms | 1 | 2013 | 3 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 407 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 2013 | 12 | 0.110 |
Why?
|
| Gamma Rays | 1 | 2013 | 25 | 0.110 |
Why?
|
| Radiation Dosage | 1 | 2013 | 32 | 0.110 |
Why?
|
| Radiation-Protective Agents | 1 | 2013 | 13 | 0.110 |
Why?
|
| Flow Cytometry | 3 | 2010 | 392 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2010 | 341 | 0.090 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 19 | 0.090 |
Why?
|
| Nanofibers | 1 | 2010 | 11 | 0.090 |
Why?
|
| Immune System Diseases | 1 | 2010 | 20 | 0.090 |
Why?
|
| Thymus Extracts | 1 | 2009 | 5 | 0.090 |
Why?
|
| Spleen | 1 | 2009 | 192 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 874 | 0.090 |
Why?
|
| Female | 5 | 2019 | 19873 | 0.080 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2004 | 2 | 0.070 |
Why?
|
| Meninges | 1 | 2004 | 6 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2004 | 38 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 58 | 0.060 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2004 | 41 | 0.060 |
Why?
|
| Aging | 1 | 2009 | 639 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2004 | 89 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 984 | 0.060 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2004 | 2 | 0.060 |
Why?
|
| Radiography, Abdominal | 1 | 2004 | 7 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 217 | 0.060 |
Why?
|
| Cryptococcus neoformans | 1 | 2004 | 55 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 105 | 0.060 |
Why?
|
| Cytokines | 1 | 2007 | 569 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 182 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 206 | 0.060 |
Why?
|
| Male | 4 | 2016 | 18870 | 0.050 |
Why?
|
| Humans | 5 | 2019 | 34853 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1149 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2010 | 116 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2019 | 11 | 0.040 |
Why?
|
| Killer Cells, Natural | 2 | 2010 | 86 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 79 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2019 | 48 | 0.040 |
Why?
|
| Adult | 2 | 2004 | 11034 | 0.040 |
Why?
|
| Esophagus | 1 | 2019 | 41 | 0.040 |
Why?
|
| Brain | 1 | 2004 | 1268 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2128 | 0.040 |
Why?
|
| DNA Damage | 1 | 2019 | 341 | 0.040 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 50 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 72 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2016 | 194 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 139 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 1530 | 0.030 |
Why?
|
| Oral Ulcer | 1 | 2013 | 3 | 0.030 |
Why?
|
| Lip | 1 | 2013 | 5 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 420 | 0.030 |
Why?
|
| Epithelium | 1 | 2013 | 74 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2013 | 135 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 151 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 211 | 0.030 |
Why?
|
| Diet | 1 | 2019 | 747 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2013 | 351 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 964 | 0.020 |
Why?
|
| Diamond | 1 | 2010 | 5 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2010 | 10 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 18 | 0.020 |
Why?
|
| Housing, Animal | 1 | 2010 | 11 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 35 | 0.020 |
Why?
|
| Platinum | 1 | 2010 | 18 | 0.020 |
Why?
|
| Drinking | 1 | 2009 | 37 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 129 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 222 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 150 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2009 | 112 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 181 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3261 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 251 | 0.020 |
Why?
|
| Phenotype | 1 | 2009 | 650 | 0.020 |
Why?
|
| Middle Aged | 1 | 2013 | 9642 | 0.010 |
Why?
|